IT1247030B - Microcrystalline form of meclophenamic acid, method and pharmaceutical formulations. - Google Patents

Microcrystalline form of meclophenamic acid, method and pharmaceutical formulations.

Info

Publication number
IT1247030B
IT1247030B ITFI910154A ITFI910154A IT1247030B IT 1247030 B IT1247030 B IT 1247030B IT FI910154 A ITFI910154 A IT FI910154A IT FI910154 A ITFI910154 A IT FI910154A IT 1247030 B IT1247030 B IT 1247030B
Authority
IT
Italy
Prior art keywords
meclophenamic acid
pharmaceutical formulations
microcrystalline form
microcrystalline
meclophenamic
Prior art date
Application number
ITFI910154A
Other languages
Italian (it)
Inventor
Roberto Villa
Luca Susanna
Original Assignee
Parke Davis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis Spa filed Critical Parke Davis Spa
Priority to ITFI910154A priority Critical patent/IT1247030B/en
Publication of ITFI910154A0 publication Critical patent/ITFI910154A0/en
Publication of ITFI910154A1 publication Critical patent/ITFI910154A1/en
Application granted granted Critical
Publication of IT1247030B publication Critical patent/IT1247030B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The microcrystalline form of meclophenamic acid is obtained by hot-dissolving the active substance in a suitable organic solvent, miscible with water, in the presence of a surfactant such as polysorbate 80, and reprecipitating the product from the solution by adding abundant water. Suitable solvents are dioxane, diethylene glycol monoethyl ether and polyethylene glycol 400, and in particular a mixture of these last two. The precipitate obtained is in the form of a white, microcrystalline powder with crystals of a diameter between 2 and 40 microns. Meclophenamic acid in the form of microcrystals is more rapidly absorbable and therefore more effective as an analgesic, especially in the formulation which can be administered in drops for oral use.
ITFI910154A 1991-06-25 1991-06-25 Microcrystalline form of meclophenamic acid, method and pharmaceutical formulations. IT1247030B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITFI910154A IT1247030B (en) 1991-06-25 1991-06-25 Microcrystalline form of meclophenamic acid, method and pharmaceutical formulations.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI910154A IT1247030B (en) 1991-06-25 1991-06-25 Microcrystalline form of meclophenamic acid, method and pharmaceutical formulations.

Publications (3)

Publication Number Publication Date
ITFI910154A0 ITFI910154A0 (en) 1991-06-25
ITFI910154A1 ITFI910154A1 (en) 1992-12-25
IT1247030B true IT1247030B (en) 1994-12-12

Family

ID=11349712

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI910154A IT1247030B (en) 1991-06-25 1991-06-25 Microcrystalline form of meclophenamic acid, method and pharmaceutical formulations.

Country Status (1)

Country Link
IT (1) IT1247030B (en)

Also Published As

Publication number Publication date
ITFI910154A1 (en) 1992-12-25
ITFI910154A0 (en) 1991-06-25

Similar Documents

Publication Publication Date Title
BG106439A (en) Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative
HK1076382A1 (en) Process for preparing a finely self-emulsifiable pharmaceutical composition
SE8300736D0 (en) NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
DK0580817T3 (en) Pharmaceutical composition and method of preparation thereof
EP0461630A3 (en) Production process of microspheres
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
EA199700201A1 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING ALKYLAMMONIUM SALTS OF 2-ARYL-PROPINIC ACIDS
MY101536A (en) Anti-inflammatory and analgesic tape for external use
AU547175B2 (en) Stabilised prostaglandin formulations
NO301542B1 (en) New pyrazine derivatives
FI913949A0 (en) Process for the preparation of a pharmaceutically useful codeine salt of a substituted carboxylic acid
GR3002386T3 (en) Salt of diclofenac with a cyclic organic base and pharmaceutical compositions which contain it
ATE67406T1 (en) PREPARATION FOR INJECTION CONTAINING NICORANDIL.
CZ316596A3 (en) NOVEL HEALING ANTIPHLOGISTIC AND ANALGESIC PHARMACEUTICAL PREPARATION CONTAINING NIMESULFIDE, i.e. N-(4-NITRO, 2-PHENYLOXYPHENYLMETHANESULFONAMIDE), FOR TRANSDERMAL APPLICATION AND PROCESS FOR PREPARING THEREOF
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
NO950134L (en) Formulations for orally administered pharmaceutical agents
IT1247030B (en) Microcrystalline form of meclophenamic acid, method and pharmaceutical formulations.
DE59005233D1 (en) New drugs and dietetics containing acylamino acid derivatives.
DE68917727D1 (en) METHOD FOR REGULATING THE ABSORPTION RATE OF MEDICINAL PRODUCTS AND MEDICINAL FORMULATION.
BG60067B2 (en) Method for preparing of 3-/(5-methyl-2-furanyl)methyl/-n-(4-piperidinyle)-3h-imidazo/4,5-b
MX9206614A (en) ARYLETHANOLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
IT1204778B (en) INJECTABLE PHARMACEUTICAL FORMULATIONS OF ACTIVE INGREDIENTS FOR GENERAL ANESTHETIC ACTIVITIES
ES8104204A1 (en) Carboxylic acid hydrazides, process for their preparation, their use and pharmaceutical compositions containing them.
KR930004460A (en) A (A) 87689 compound
ES2141049A1 (en) Aerosol pharmaceutical formulations which contain medium- chain triglycerides as surfactants.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970415